Two individuals (2 of 157; 1.3%) with a P/LP TTR variant (T60A [same patient as above] and V122I) had a diagnosis of noncardiac-specific (general) amyloidosis compared to 136 controls without a P/LP TTR variant (136 of 134,596; 0.1%). This evidence concerns the gene TTR and amyloidosis.